Financial Impact of Alternative Pricing Benchmarks for Physician-Dispensed Drugs in the California Workers ’ Compensation System

ConclusionsThe CAWCS current Medi-Cal pricing for physician-dispensed drugs is better than all alternatives in terms of price availability, transparency, and budget neutrality, but pricing availability may decrease over time as Medi-Cal moves to managed care. National average drug acquisition cost is the next best alternative, but it requires combinations of pricing benchmarks to maximize its price availability.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research